196 related articles for article (PubMed ID: 32399641)
1. Long-term Kinetic Papilledema Improvement After Venous Sinus Stenting in Idiopathic Intracranial Hypertension.
Touzé R; Bonnin S; Houdart E; Nicholson P; Bodaghi B; Shotar E; Clarençon F; Lenck S; Touitou V
Clin Neuroradiol; 2021 Jun; 31(2):483-490. PubMed ID: 32399641
[TBL] [Abstract][Full Text] [Related]
2. Idiopathic Intracranial Venous Hypertension: Toward a Better Understanding of Venous Stenosis and the Role of Stenting in Idiopathic Intracranial Hypertension.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2023 Dec; 43(4):451-463. PubMed ID: 37410913
[TBL] [Abstract][Full Text] [Related]
3. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
4. Neuro-ophthalmological evaluation including optical coherence tomography surrounding venous sinus stenting in idiopathic intracranial hypertension with papilledema: a case series.
Hendrix P; Whiting CJ; Griessenauer CJ; Bohan C; Schirmer CM; Goren O
Neurosurg Rev; 2022 Jun; 45(3):2239-2247. PubMed ID: 35067804
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of papilledema and visual improvement in patients with idiopathic intracranial hypertension after venous sinus stenting].
Wang W; Jia Q; Fan YM; Li XD; Wang SB; Cheng L; Wang HG; Liang WL; Bian LZ; Tong XG
Zhonghua Wai Ke Za Zhi; 2021 Dec; 59(12):1012-1017. PubMed ID: 34839617
[No Abstract] [Full Text] [Related]
6. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography.
Smith KA; Peterson JC; Arnold PM; Camarata PJ; Whittaker TJ; Abraham MG
Int J Neurosci; 2017 Feb; 127(2):145-153. PubMed ID: 26863329
[TBL] [Abstract][Full Text] [Related]
7. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri.
Cappuzzo JM; Hess RM; Morrison JF; Davies JM; Snyder KV; Levy EI; Siddiqui AH
Neurosurg Focus; 2018 Jul; 45(1):E11. PubMed ID: 29961386
[TBL] [Abstract][Full Text] [Related]
8. Endovascular Treatment for Venous Sinus Stenosis in Idiopathic Intracranial Hypertension: An Observational Study of Clinical Indications, Surgical Technique, and Long-Term Outcomes.
Shields LBE; Shields CB; Yao TL; Plato BM; Zhang YP; Dashti SR
World Neurosurg; 2019 Jan; 121():e165-e171. PubMed ID: 30248468
[TBL] [Abstract][Full Text] [Related]
9. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study.
Liu KC; Starke RM; Durst CR; Wang TR; Ding D; Crowley RW; Newman SA
J Neurosurg; 2017 Nov; 127(5):1126-1133. PubMed ID: 28009240
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of dural venous sinus stenting in treating idiopathic intracranial hypertension with acute vision loss.
Zehri AH; Lee KE; Kartchner J; Arnel M; Martin T; Wolfe SQ; Fargen KM
Neuroradiol J; 2022 Feb; 35(1):86-93. PubMed ID: 34224285
[TBL] [Abstract][Full Text] [Related]
11. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
12. Management of idiopathic intracranial hypertension in children utilizing venous sinus stenting.
Schwarz J; Al Balushi A; Sundararajan S; Dinkin M; Oliveira C; Greenfield JP; Patsalides A
Interv Neuroradiol; 2021 Apr; 27(2):257-265. PubMed ID: 33236688
[TBL] [Abstract][Full Text] [Related]
13. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
[TBL] [Abstract][Full Text] [Related]
14. Emergent cerebral venous stenting: A valid treatment option for fulminant idiopathic intracranial hypertension.
Horev A; Ben-Arie G; Walter E; Tsumi E; Regev T; Aloni E; Biederko R; Zlotnik Y; Lebowitz Z; Shelef I; Honig A
J Neurol Sci; 2023 Sep; 452():120761. PubMed ID: 37572407
[TBL] [Abstract][Full Text] [Related]
15. Follow-up of mild papilledema in idiopathic intracranial hypertension with optical coherence tomography.
Rebolleda G; Muñoz-Negrete FJ
Invest Ophthalmol Vis Sci; 2009 Nov; 50(11):5197-200. PubMed ID: 19011007
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of optic nerve head changes with optic coherence tomography in patients with idiopathic intracranial hypertension.
Eren Y; Kabatas N; Guven H; Comoglu S; Gurdal C
Acta Neurol Belg; 2019 Sep; 119(3):351-357. PubMed ID: 30120685
[TBL] [Abstract][Full Text] [Related]
17. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis.
Nicholson P; Brinjikji W; Radovanovic I; Hilditch CA; Tsang ACO; Krings T; Mendes Pereira V; Lenck S
J Neurointerv Surg; 2019 Apr; 11(4):380-385. PubMed ID: 30166333
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of venous sinus stenting in the treatment of idiopathic intracranial hypertension.
Cheng H; Jin H; Hu Y; Chen L; Chen Z; Zhong G
CNS Neurosci Ther; 2024 Jan; 30(1):e14356. PubMed ID: 37469247
[TBL] [Abstract][Full Text] [Related]
19. Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients.
Kabatas N; Eren Y; Nalcacioglu P; Caliskan S; Bicer T; Comoglu SS; Gurdal C
Int Ophthalmol; 2021 Apr; 41(4):1467-1477. PubMed ID: 33481155
[TBL] [Abstract][Full Text] [Related]
20. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
